Gilgamesh Pharmaceuticals logo

Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals is a pharmaceutical platform company developing an oral arylcyclohexylamine therapeutic and the next generation of psychedelic-related medicines.

1

Funding Rounds

$27.0m

Money raised

Overview

Gilgamesh Pharmaceuticals is a pharmaceutical platform company developing an oral arylcyclohexylamine therapeutic and the next generation of psychedelic-related medicines.

Funding series

Funding Series Analysis

The company Gilgamesh Pharmaceuticals has raised a total of $27m in funding over 1 rounds.

Key Insights:

  • Gilgamesh Pharmaceuticals Series A round, May 2021: $27m
Gilgamesh Pharmaceuticals logo
Gilgamesh Pharmaceuticals Series A round, May 2021 $27m

Industries

Gilgamesh Pharmaceuticals is active in the following industries: